MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00134-024-07489-2

Медицинская библиотека · Intensive care medicine · 2024

Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study.

Kamel Toufik, Janssen-Langenstein Ralf, Quelven Quentin, Chelly Jonathan, Valette Xavier, Le Minh-Pierre, Bourenne Jeremy, Garot Denis, Fillatre Pierre, Labruyere Marie, Heming Nicholas, Lambiotte Fabien, Lascarrou Jean-Baptiste, Lesieur Olivier, Bachoumas Konstantinos, Ferre Alexis, Maury Eric, Chalumeau-Lemoine Ludivine, Bougon David, Roux Damien, Guisset Olivier, Coudroy Remi, Boulain Thierry, PCP-MULTI Study group

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: Severe Pneumocystis jirovecii pneumonia (PJP) requiring intensive care has been the subject of few prospective studies. It is unclear whether delayed curative antibiotic therapy may impact survival in these severe forms of PJP. The impact of corticosteroid therapy combined with antibiotics is also unclear.

METHODS

This multicentre, prospective observational study involving 49 adult intensive care units (ICUs) in France was designed to evaluate the severity, the clinical spectrum, and outcomes of patients with severe PJP, and to assess the association between delayed curative antibiotic treatment and adjunctive corticosteroid therapy with mortality.

RESULTS

We included 158 patients with PJP from September 2020 to August 2022. Their main reason for admission was acute respiratory failure (n = 150, 94.9%). 12% of them received antibiotic prophylaxis for PJP before ICU admission. The ICU, hospital, and 6-month mortality were 31.6%, 35.4%, and 40.5%, respectively. Using time-to-event analysis with a propensity score-based inverse probability of treatment weighting, the initiation of curative antibiotic treatment after 96 h of ICU admission was associated with faster occurrence of death [time ratio: 6.75; 95% confidence interval (95% CI): 1.48-30.82; P = 0.014]. The use of corticosteroids for PJP was associated with faster occurrence of death (time ratio: 2.48; 95% CI 1.01-6.08; P = 0.048).

CONCLUSION

This study showed that few patients with PJP admitted to intensive care received prophylactic antibiotic therapy, that delay in curative antibiotic treatment was common and that both delay in curative antibiotic treatment and adjunctive corticosteroids for PJP were associated with accelerated mortality.

Для цитирования: Kamel Toufik, Janssen-Langenstein Ralf, Quelven Quentin, Chelly Jonathan, Valette Xavier, Le Minh-Pierre, Bourenne Jeremy, Garot Denis, Fillatre Pierre, Labruyere Marie, Heming Nicholas, Lambiotte Fabien, Lascarrou Jean-Baptiste, Lesieur Olivier, Bachoumas Konstantinos, Ferre Alexis, Maury Eric, Chalumeau-Lemoine Ludivine, Bougon David, Roux Damien, Guisset Olivier, Coudroy Remi, Boulain Thierry, PCP-MULTI Study group. Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study.. Intensive care medicine. 2024. DOI: 10.1007/s00134-024-07489-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.